A relatively high number of FoxP3+ Treg cells, resulting in a decreased CD8+/FoxP3+ ratio, is also significantly associated with shorter overall survival in the majority of solid tumors investigated, including breast cancer [18–20]. Here, FOXP3 is linked to breast cancer.